• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home AI Roundup

Abridge drafts pediatric notes so physicians stay with the kids, not the keyboard

byDeepti Shroff Karhade
July 7, 2025
in AI Roundup
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Key points:

1. Abridge closed a $300 million Series E and launched an inpatient module integrated with Epic that speeds up note completion and reduces after-hours charting.

2. The company’s ambient AI tools are expanding rapidly, with projections for 50 million encounters this year and international expansion plans underway.

Pittsburgh start-up Abridge closed a $300 million Series E on June 24 that doubled its valuation to $5.3 billion. The funding coincided with Abridge Inside for Inpatient, an Epic-integrated module that converts bedside talk to structured notes. Sutter Health pilots show progress-note closure in under two minutes, according to the launch release. A pediatric template has earned an average 4.5-star rating across 25 000 encounters, feedback summarized in an Abridge blog. Digital Health Wire reports the platform now supports 150-plus enterprise systems and is on pace for 50 million encounters this year. The inpatient build emerged from Epic’s Workshop track, a co-development route Business Wire says cuts security review cycles by 60 percent. CEO Shiv Rao told MedCity News that a revenue-cycle copilot, now training on 12 million labeled claims, hits 98 percent first-pass acceptance in payer pilots. A HFMA session projected that even a one-point coding lift could yield hospitals $700 million over three years. Nemours Children’s reported a 32 percent drop in after-hours charting during a six-week evaluation, results shared in a JAMA Network Open preprint. User sentiment measured by KLAS Research shows a four-point net-promoter gain among Abridge adopters. Rao plans specialty templates for neonatology and oncology by Q4, expanding the addressable market 40 percent. Foley & Lardner’s health-tech brief ranks the round as the second-largest digital-scribe deal ever. International expansion talks are under way in the U.K. and Australia, where Epic penetration is rising. Ambient AI appears to be pivoting from novelty to necessity for documentation-burdened clinicians.

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

2 Minute Medicine Rewind August 18, 2025

Overweight body habitus is associated with higher rates of relapse in children with acute lymphoblastic leukemia

2MM: AI Roundup Free AI Scribes, Smarter Heart Ultrasounds, Faster NHS Physio, and Preventive-Care AI [August 7th 2025]

Tags: artificial intelligencenotespediatricsscribe
Previous Post

AAV gene therapy shows durable benefit in hemophilia B

Next Post

Approved label populations may be broader than trial populations for new drugs

RelatedReports

Few high school students, young adults get HIV testing
Weekly Rewinds

2 Minute Medicine Rewind August 18, 2025

August 18, 2025
Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors
Chronic Disease

Overweight body habitus is associated with higher rates of relapse in children with acute lymphoblastic leukemia

August 7, 2025
2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]
AI Roundup

2MM: AI Roundup Free AI Scribes, Smarter Heart Ultrasounds, Faster NHS Physio, and Preventive-Care AI [August 7th 2025]

August 7, 2025
AI Roundup

Kenya’s AI Consult reduces errors in 20000 clinical encounters

August 14, 2025
Next Post
A stethoscope intertwined with a compass

Approved label populations may be broader than trial populations for new drugs

Majority of obese tenth-graders already obese by fifth grade

Body mass index-specific waist circumference thresholds may improve mortality risk stratification in women

Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease

Fecal calprotectin is a useful marker for defining small bowel endoscopic remission in Crohn's disease

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Extended aromatase inhibitor therapy reduces breast cancer recurrence in postmenopausal women
  • GSK and Hengrui Pharma Forge $500 Million China Collaboration
  • #VisualAbstract: Ciprofloxacin is Noninferior to Aminoglycoside–Ciprofloxacin for Treatment of Bubonic Plague
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.